X

Aarti Pharmalabs Ltd Q2FY24; 2% rise in Profits

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals

Financial Results:

Aarti Pharmalabs Ltd reported Revenues for Q2FY24 of ₹440.00 Crores down from ₹531.00 Crore year on year, a fall of 17.14%.

Total Expenses for Q2FY24 of ₹374.00 Crores down from ₹464.00 Crores year on year, a fall of 19.4%.

Consolidated Net Profit of ₹52.00 Crores up 1.96% from ₹51.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹5.72, from ₹NaN.00 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post